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P. Venugopal, MCh,a New Delhi, India
Premature coronary artery occlusive disease infamilial homozygous hypercholesterolemiamight necessitate coronary bypass surgery inchildren and young adults. Arterial grafts have
been shown to be superior to venous grafts in children,
with longer patency rates and a better growth poten-
tial.1,2 Young adults with familial hypercholesterolemia also fare better with internal thoracic
grafts, although the benefit of multiple arterial grafts is still unproved in this setting.3,4
Surgical angioplasty of the main coronary arteries is another alternative to preserve the
precious arterial conduits for future reoperations.5 Saphenous venous grafts, although infe-
rior, have also been found to have some growth potential and long-term patency, even up to
22 years.6,7
The subject of this report is a 12-year-old child with familial homozygous hypercholes-
terolemia and severe obstructive coronary artery disease who underwent a total arterial
revascularization. To the best of our knowledge, this is the first report of total arterial
revascularization at this age.
Clinical Summary
A 12-year-old boy (weight, 22 kg) presented to our cardiac clinic with a history of exertional
angina of more than 2 years’ duration. His anginal symptoms had shown recent worsening
with frequent rest pains, and at present, he was unable to walk even 100 m without becoming
symptomatic. He had a strong family history of hypercholesterolemia, premature coronary
artery disease, and death but had no other classic major risk factors. He had multiple
tendinous xanthomas over his fingers, elbow and knee joints, and Achilles tendon. He was
being treated with statins, but the lipid profile was grossly deranged, with a total cholesterol
level of 670 mg/dL, low-density lipoprotein (LDL) cholesterol level of 600 mg/dL, high-
density lipoprotein cholesterol level of 39 mg/dL, and triglyceride level of 136 mg/dL.
Electrocardiography showed reversible ST-T depression in lateral leads. Echocardiographic
Doppler scanning revealed mild aortic regurgitation and trivial mitral regurgitation. Coronary
angiography showed severe left main and proximal right coronary artery disease (Figure 1).
He was treated with intravenous nitroglycerin, -blockers, angiotensin-converting enzyme
inhibitors, and aspirin, along with lipid-lowering drugs.
He was taken up for myocardial revascularization. The bilateral internal thoracic artery
(ITA; pedicle graft) and the left radial artery (free graft) were harvested. The left ITA/right
ITA measured 1 mm, and the radial artery measured 1.5 mm. During cardiopulmonary bypass
and cardioplegic arrest, the left anterior descending artery and the right coronary artery were
revascularized with the left and right ITA, respectively, and the obtuse marginal artery was
revascularized with the radial artery. The child became asymptomatic after coronary artery
bypass grafting (CABG), and a cineangiogram on the 12th postoperative day showed patent
arterial grafts with no anastomotic problems (Figure 2).
The child was started on bezafibrate and cholestyramine (INN: colestyramine) in addition
to atorvastatin. Plasmapheresis and LDL apheresis could not be carried out because of the
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high recurrent cost of these procedures, which the family could not
afford. Similarly, partial liver transplantation was not considered
because of financial reasons and also because this facility is as yet
not fully developed in our country. Lipid control has remained
suboptimal, with LDL cholesterol still greater than 300 mg%. The
child has been free of angina over the past 1 year.
Discussion
Familial hypercholesterolemia is an autosomal dominant disorder
in which mutation in the gene encoding the LDL receptor causes
a high plasma level of cholesterol, with accelerated atherosclerosis
and development of multiple tendon xanthomas. Although the
common age of presentation is late in the second and third decade,
earlier presentation with severe obstructive coronary artery disease
is well documented.8 The youngest child reported to have under-
gone CABG for familial hypercholesterolemia is a 7-year-old in
whom the left ITA measured only 1 mm, and venous grafts were
made to the left anterior descending artery and the right coronary
artery.8 The benefits of arterial grafts in older patients with familial
hypercholesterolemia have been documented in several studies in
terms of actuarial survival and freedom from symptoms.3,4 Ag-
gressive lipid lowering with LDL apheresis and plasmapheresis is
extremely important to prevent recurrence, and new lesions occur
if total cholesterol remains greater than 220 mg%.9,10
The use of arterial conduits for coronary problems in infants
and children is now well accepted, with excellent long-term pa-
tency and growth in children with Kawasaki disease, postarterial
switch, and other congenital coronary lesions.1,2 Differences in
adaptation to growth of children have been shown between arterial
and venous grafts, with thoracic artery growing in proportion to
somatic growth, whereas saphenous vein grafts tend to course in a
more linear way, with no increase in length or diameter.11 How-
ever, isolated reports have highlighted excellent growth and pa-
tency of venous grafts up to 22 years after bypass surgery.6,7
Surgical coronary angioplasty of the left main artery has also been
shown to be effective in the midterm and is useful in avoiding
venous and arterial conduits and preserving these for later reop-
erations.5
In our patient, a 12-year-old boy with left main disease and
disease of the proximal right coronary artery, we revascularized
Figure 1. Aortic root injection in the left anterior oblique view
showing a tight left main coronary artery (LMCA) lesion and a
proximal right coronary artery (RCA) lesion.
Figure 2. A, Postoperative angiogram showing a patent left in-
ternal thoracic artery (LIMA) to left anterior descending artery
(LAD) anastomosis. B, Postoperative angiogram showing a patent
right internal thoracic artery (RIMA) to right coronary artery (RCA)
anastomosis. C, Postoperative angiogram showing a patent left
radial artery to obtuse marginal artery anastomosis.
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the vessels with total arterial grafts, despite the technical difficul-
ties of harvesting and anastomosing the conduits. Whether multi-
ple arterial grafts in this setting provide a better long-term outcome
is not known from the available limited literature.3 The gastroepi-
ploic artery has been used as the additional arterial conduit in
patients with Kawasaki disease, but we are not aware of the use of
the radial artery in children.1 We preferred the radial artery be-
cause of its adequate size and length and also because of its being
an arterial conduit. We chose to do a total arterial revasculariza-
tion, expecting better long-term patency, especially when aggres-
sive lipid lowering was not possible, and our patient can hardly
afford an early redo operation that would be more likely with
venous conduits. The patency of autologous saphenous vein in
children is not satisfactory. The patency of the vein graft is 65.4%
 7.9% 84 months after the operation in those of more than 8 years
of age but only 27.7%  8.1% (P  .01) in those younger than 7
years of age.12 Furthermore, surgical expertise in performing
CABG in adults and neonatal arterial switch allowed the con-
cerned surgeon (AB) to be confident of a good anastomotic result.
In conclusion, we describe total arterial revascularization in a
young boy with familial hypercholesterolemia. Whether such a
strategy in the absence of measures like LDL apheresis and plas-
mapheresis can be better than venous grafts is not known. In
developing countries, in which financial difficulties prevent routine
use of such expensive treatment regimens, this could be an alter-
native that allows better long-term outcome.
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